United Kingdom Holding Companies

Achilles Therapeutics PLC (ACHL)

Track

Ticker: ACHL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 3 Mar 2025
Value US$4,620,679.21 | Price 456.70 | Shares 48,760
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-03-03 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
48,760
456.70
US$4,620,679 		48,760 456.70 US$4,620,679
2025-03-03 2025-03-03 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
66,388
29.20
US$4,136,016 		66,388 29.20 US$4,136,016
2025-02-18 2025-02-13 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
83,617
96.92
US$574,033 		83,617 96.92 US$574,033
2025-02-11 2025-02-06 PrS Proposed sale
Ehmer Bernhard

Director; Former Director

Non-Executive Director
38,750
1.38
US$53,537 		38,750 1.38 US$53,537
2025-02-07 2025-02-06 PrS Proposed sale
Moses Edwin

Director

Non-Executive Director
25,000
1.38
US$34,500 		25,000 1.38 US$34,500
2025-02-05 2025-02-05 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
75,024
1.23
US$91,956 		75,024 1.23 US$91,956
2025-02-06 2025-02-04 PrS Proposed sale
3.0
Giordano Michael F

Former Director

Non-Executive Director
25,000
1.39
US$34,815 		25,000 1.39 US$34,815
2025-02-06 2025-02-04 PrS Proposed sale
BOESS CARSTEN

Director

Non-Executive Director
25,000
1.36
US$34,004 		25,000 1.36 US$34,004
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
13,750
1.37
US$18,857 		13,750 1.37 US$18,857
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
25,000
1.37
US$34,250 		25,000 1.37 US$34,250
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
246
1.19
US$292 		246 1.19 US$292
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
68,814
1.17
US$80,621 		68,814 1.17 US$80,621
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,337 		50,000 1.29 US$64,337
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,453 		50,000 1.29 US$64,453
2025-02-05 2025-02-04 PrS Proposed sale
Quezada Sergio Andres

Former Officer

Officer
67,437
1.37
US$92,265 		67,437 1.37 US$92,265
2024-02-01 2024-02-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
30,000
0.93
US$27,900 		30,000 0.93 US$27,900
2023-11-01 2023-11-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.86
US$30,100 		35,000 0.86 US$30,100
2023-08-17 2023-08-17 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.94
US$32,735 		35,000 0.94 US$32,735
Explore more

More insider trading research around Achilles Therapeutics PLC

More insider trades in United Kingdom
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in Europe